Leap Distributors Taps Veteran CFO Dave Ascani to Steer Next Growth Phase

DALLAS, TX – July 28, 2026 – In a strategic move signaling a commitment to accelerated growth, national medical device distribution partner Leap Distributors has named Dave Ascani as its new chief financial officer (CFO). Ascani will take the helm of the company’s finances, joining the executive team to guide its next stage of development in the highly competitive healthcare sector.

“Dave Ascani is a seasoned financial executive with a long and distinguished career of helping companies to achieve their financial goals and enable continued, strategic growth,” said Leap Distributors CEO Allen Mason. “We look forward to having him join us during this stage in our development.”

For his part, Ascani expressed enthusiasm for the company’s dynamic position in the market. “These guys are the ‘rock stars’ of medical device distribution,” said Ascani. “I’m excited to join them as we work together to take Leap Distributors to the next level.”

A Veteran Financier for a Growth-Stage Innovator

Ascani brings over 40 years of leadership expertise that spans a diverse range of industries, including distribution, manufacturing, telecommunications, software, and logistics. His career is marked by a consistent ability to architect financial strategies that produce tangible results. As a proven financial thought leader, Ascani specializes in driving transformational change that grows revenue, reduces operational costs, and improves profit margins—a trifecta of skills critically needed for companies poised for expansion.

His track record speaks for itself. Previously, Ascani served as CFO of Network Wireless Solutions LLC, a wholesale distributor where he was instrumental in more than doubling the company’s annual revenue from $105 million to over $260 million. This experience in rapidly scaling a distribution business is directly applicable to Leap’s ambitions.

Further demonstrating his strategic prowess, he managed complex corporate maneuvers as CFO of the SaaS software company SecureNet Technologies, where he led the company’s integration with an overseas hardware manufacturer and steered the due diligence process for a successful sale-exit transaction. This expertise in M&A and integrations is particularly relevant for Leap, which has already demonstrated an appetite for strategic acquisitions.

At Merit Distribution Group LLC, a private equity-owned entity with over $520 million in annual revenue, Ascani held the dual role of CFO and CIO. There, he was responsible for the financial and systems management of two wholesale distribution entities across 50 locations. His tenure included successfully leading the company through a sale process as well as orchestrating seven different acquisitions and integrations. Before his time in the private sector, Ascani had a distinguished 20-year career in the U.S. Air Force, retiring as a Lieutenant Colonel. His military service, where he received federal recognition as one of the Air Force’s top financial planning professionals, instilled a deep discipline in strategic resource management that continues to define his leadership style.

Fortifying Leadership for Strategic Market Ascent

The appointment of a CFO with Ascani’s background is a calculated move for Leap Distributors. The company operates within the vast and expanding medical device distribution market, a sector estimated to surpass $55 billion in 2026 and projected to grow at a CAGR of over 8%. While the industry is dominated by giants like Cardinal Health and Medline, which serve the majority of U.S. hospitals, Leap has carved out a powerful niche. The company positions itself as an “operating system for independent distribution,” empowering smaller distributors and manufacturers with streamlined market access, GPO strategy, and end-to-end logistics.

Supporting over 10,000 surgeries annually and partnering with more than 750 surgeons and 350 facilities, Leap has already established a significant operational footprint. Its 2024 acquisition of Leap Surgical and DUB Enterprises signaled a clear strategy of growth through consolidation and service expansion. Bringing Ascani on board is the logical next step in this strategic journey. His extensive experience with private equity-backed companies and his proven ability to manage rapid scaling and complex M&A activities provide the exact financial stewardship required to elevate Leap from a strong niche player to a formidable market force. His leadership is expected to be pivotal in securing the necessary capital, optimizing resource allocation, and identifying new strategic opportunities for acquisition and partnership.

Navigating the Complex Future of MedTech Distribution

Ascani joins Leap at a time of significant transformation within the healthcare supply chain. The industry faces a confluence of powerful trends and persistent challenges. The shift towards home healthcare, the rise of sophisticated medical technologies like AI-powered diagnostics and robotics, and the increasing demand for supply chain transparency are reshaping how medical devices reach clinicians and patients. Simultaneously, distributors must contend with intense pricing pressure, complex regulatory landscapes, and the ever-present risk of supply chain disruptions.

In this dynamic environment, financial leadership becomes synonymous with strategic foresight. A modern CFO must do more than balance the books; they must architect a financial framework that fosters resilience, innovation, and efficiency. Ascani’s expertise in logistics, distribution, and cost reduction is perfectly suited to this task. His role will involve guiding critical investments in the IT infrastructure and digital inventory management systems necessary to compete in an increasingly digitized marketplace. Furthermore, his disciplined approach to financial planning will be essential for navigating the high capital expenditures and regulatory hurdles inherent to the medical device sector.

By strengthening its financial leadership, Leap Distributors is not only preparing for growth but is also building the operational robustness required to thrive amidst industry-wide pressures. The goal is to ensure that as medical technology becomes more innovative, the supply chain that delivers it becomes more intelligent, efficient, and reliable. Ascani’s appointment is a clear declaration of Leap’s intent to lead that charge, ensuring that the company can continue to effectively power a more efficient model of medical device distribution that ultimately improves patient care.